Carl Zeiss Meditec AG
Company Profile
Business description
Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
Contact
Goschwitzer Strasse 51-52
JenaTH07745
DEUT: +49 3641220115
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 September 2025
Employees
5,713
Stocks News & Analysis
stocks
10 best US dividend aristocrats to buy now—including a surprise outperformer
stocks
Leading ASX players in this field look materially overvalued
stocks
After earnings, is Alphabet stock a buy, a sell, or fairly valued?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,970.50 | 44.90 | -0.50% |
CAC 40 | 7,861.96 | 4.60 | 0.06% |
DAX 40 | 24,262.22 | 44.85 | 0.19% |
Dow JONES (US) | 44,461.28 | 171.71 | -0.38% |
FTSE 100 | 9,136.94 | 0.62 | 0.01% |
HKSE | 25,176.93 | 347.52 | -1.36% |
NASDAQ | 21,129.67 | 31.38 | 0.15% |
Nikkei 225 | 40,814.94 | 160.24 | 0.39% |
NZX 50 Index | 12,850.18 | 5.79 | -0.05% |
S&P 500 | 6,362.90 | 7.96 | -0.12% |
S&P/ASX 200 | 8,713.40 | 43.00 | -0.49% |
SSE Composite Index | 3,615.72 | 6.01 | 0.17% |